U.S. Food and Staples Retail Stock News

CarGurus (CARG) has been drawing attention after recent share price moves, with the stock now around US$34.74. For investors, the key question is how this lines up with the company’s fundamentals. See our latest analysis for CarGurus. Recent trading has been choppy, with a 7 day share price return of a 10.05% decline and a 30 day share price return of a 9.03% decline. However, the 3 year total shareholder return of 119.73% points to much stronger longer term momentum that has cooled...

Urban Edge Properties (UE) is drawing attention after a mixed return picture. The stock has been roughly flat over the past year, while showing gains over the past 3 years and 5 years. See our latest analysis for Urban Edge Properties. The recent 7 day and 30 day share price returns of 3.57% and 4.11% declines, alongside a 6.14% decline over 90 days, suggest momentum has cooled recently even though the 3 year and 5 year total shareholder returns of 38.52% and 60.52% still point to a stronger...

If you are wondering whether Tripadvisor's current share price reflects its real worth, you are not alone. Many investors are asking whether the stock still offers value after a tough run. The shares last closed at US$13.99, with returns of a 5.7% decline over 7 days, 6.4% decline over 30 days, 4.4% decline year to date, 10.7% decline over 1 year, 35.8% decline over 3 years and 58.4% decline over 5 years. This performance has naturally raised questions about both risk and potential...

If you are wondering whether Gap's current share price really reflects its underlying value, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$27.28, with a 4.0% decline over the last 7 days, a 0.8% gain over 30 days, 8.3% gain year to date, 23.7% gain over 1 year, and a very large 3 year return that is around 1.4x, alongside a 46.3% gain over 5 years. These figures can change how investors think about both risk and opportunity. Recent...

Sana Biotechnology (SANA) used its appearance at the 44th Annual J.P. Morgan Healthcare Conference to share updated data on its UP421 cell therapy and pipeline programs SC451 and SG293, sharpening the story around its clinical progress. See our latest analysis for Sana Biotechnology. Those conference updates land after a mixed stretch for the stock, with a 7 day share price return of 3.32% compared with a 30 day share price return decline of 6.60%. Meanwhile, the 1 year total shareholder...

Why SPX Technologies is on investors’ radar today SPX Technologies (SPXC) has drawn fresh attention after recent trading left the stock around $213.61, with performance over the past month, past 3 months, and year giving investors more data to assess. See our latest analysis for SPX Technologies. The recent move to a share price of $213.61 comes after a 1-day share price return of 1.83% and a 7-day share price return of 2.97%, set against a 90-day share price return of 16.07% and a 1-year...

Context for Marvell Technology’s recent share performance Marvell Technology (MRVL) has seen its share price under pressure recently, with returns of 1% for the day, 3.7% over the past week, and a 4.4% decline over the past month. Over the past 3 months the stock is down 8.6%, and the 1 year total return is a 31.4% decline, even though the 3 year and 5 year total returns remain positive. See our latest analysis for Marvell Technology. At a share price of $80.38 and with a 1 year total...

Wondering whether Gentex shares offer fair value at around US$24, or if the current price is leaving something on the table for patient investors? The stock is roughly flat over the past month with a 0.3% return, but that sits against a 10.9% decline over the last year and a 28.7% decline over five years. This performance may have shifted how the market views its risk and potential. Recent coverage has focused on Gentex as an established auto parts name on the Nasdaq, with investors watching...

KeyBanc’s downgrade of Mach Natural Resources (MNR) to Sector Weight, tied to integration hurdles around new Central Basin Platform and San Juan Basin assets and reduced capital spending, has pushed investors to reassess the partnership’s near term outlook. See our latest analysis for Mach Natural Resources. At a share price of $11.01, Mach Natural Resources has seen pressure build over the past quarter, with a 90 day share price return of 7.25% and a 1 year total shareholder return decline...

If you are wondering whether W. P. Carey is fairly priced or if there is still value on the table, this article will walk you through what the current share price might be telling you. The stock last closed at US$68.92, with returns of 2.2% over 7 days, 6.1% over 30 days, 6.3% year to date, 31.3% over 1 year, 2.2% over 3 years, and 41.1% over 5 years. Taken together, these figures give you a broad picture of how the market has treated the shares across different time frames. Recent coverage...

Why Restaurant Brands International Is On Investor Radars Today Restaurant Brands International (QSR) has caught investor attention recently, with the stock showing mixed short term moves, including a small 1 day decline alongside a modest gain over the past week. See our latest analysis for Restaurant Brands International. While the 1 day share price return of 0.5% decline might catch the eye, the 90 day share price return of 3.19% and 1 year total shareholder return of 19.33% suggest...

Recent performance snapshot Criteo (CRTO) is back on some investors’ radars after a mixed stretch, with the share price showing small moves over the past week and month, and a modest gain in the past 3 months. That recent pattern sits against a longer history where the stock shows a 45.3% negative total return over the past year and a 27% negative total return over 3 years, partly offset by an 8.5% positive total return over 5 years. See our latest analysis for Criteo. At a share price of...

If you are wondering whether General Motors' current share price still offers value, this article walks through what the numbers suggest and how that might fit with your own expectations. The stock closed at US$80.91, with a 5.0% decline over the last 7 days and a 1.0% decline over 30 days, while the 1 year return stands at 57.7% and the 3 year return at 133.6%. Recent coverage has focused on General Motors as a key player in US autos, including its push in areas such as electric vehicles...

Ultra Clean Holdings, Inc. recently presented at the 28th Annual Needham Growth Conference in New York, outlining its role supplying critical cleaning and contamination control equipment for semiconductor manufacturing and AI chip production. The company’s commentary on operational execution, gross margin strength, and its importance to AI-focused semiconductor infrastructure has sharpened investor focus on how it might participate in any broader industry recovery. We’ll now examine how...

Xcel Energy (XEL) is back in focus as investors look ahead to its upcoming fiscal Q4 2025 earnings report and its expanded five year, US$60b capital investment plan. See our latest analysis for Xcel Energy. At a share price of US$75.36, Xcel Energy has seen a 2.7% 7 day share price return and a 2.21% 30 day share price return, while its 1 year total shareholder return of 17.55% and 5 year total shareholder return of 35.63% point to momentum that has built over time despite a softer 90 day...

Investors may be asking whether Collegium Pharmaceutical at around US$46.90 is offering good value right now, or if most of the upside has already been priced in. The share price has seen mixed recent returns, with a 3.9% decline over the past week and a 3.7% decline over the past month, while still sitting on a 40.2% return over 1 year and 98.6% over 5 years. Recent coverage has focused on how investors are reassessing specialty pharmaceutical names like Collegium Pharmaceutical in light of...

monday.com (MNDY) moved back into focus after Barclays cut its expectations on the stock, pointing to softer revenue guidance for late 2025 that indicated slower growth in a still-volatile tech sector. See our latest analysis for monday.com. At a share price of $132.81, monday.com has seen pressure build over recent months, with a 30-day share price return of 11.54% and a 90-day share price return of 26.86%, while the 1-year total shareholder return of 44.80% contrasts with a 3-year total...

AtaiBeckley Inc. recently outlined its 2026 development plans and reported prior positive Phase 2b and extension data for BPL-003 in treatment-resistant depression, alongside progress on VLS-01 and EMP-01, while also announcing the immediate resignation of board member Cosmo Feilding-Mellen with no stated disagreement. The selection of BPL-003 Phase 2b results for a high-profile “Hot Topics” session at a major neuropsychopharmacology meeting underscores the growing scientific interest around...

Earlier in 2026, American Bitcoin Corp reiterated that it ranks among the top twenty publicly traded Bitcoin treasury holders, disclosing reserves of over 5,098 Bitcoin and unveiling a new Bitcoin Yield Metric alongside its existing Satoshis Per Share measure. This move signals an effort to give investors clearer insight into how its sizable Bitcoin holdings behave over time, using metrics tailored specifically to Bitcoin exposure rather than traditional accounting alone. Next, we’ll examine...

If you are wondering whether Harrow's share price still makes sense after recent moves, you are not alone and the numbers give us plenty to talk about. The stock trades at US$48.49, with a 7 day return of a 5% decline, a 30 day return of 8.3% and a 1 year return of 44.9%, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Harrow has mainly focused on its position in the pharmaceuticals and biotech space and investor interest in how its...

What recent performance says about DaVita (DVA) DaVita (DVA) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months, as well as over the past year. At a last close of $105.84, DaVita sits below its one-year total return level, which is down 35.8%. Over the past month and past 3 months, returns of 10.3% and 15.9% declines highlight recent pressure on the share price. See our latest analysis...

Technical trigger and rising expectations around Adeia Adeia (ADEA) recently posted a golden cross, where its 50 day moving average moved above the 200 day level. This occurred alongside upward revisions to current quarter earnings estimates, drawing fresh attention from technically focused and fundamentally oriented investors alike. See our latest analysis for Adeia. That technical setup is arriving alongside strong momentum, with Adeia’s 1 month share price return of 47.12% and 1 year total...

In recent days, Postal Realty Trust has drawn attention as technical models flagged its shares as a momentum candidate, while the company continued to expand its USPS‑leased portfolio with 216 acquisitions in 2025 and maintained 99.8% occupancy alongside a largely fixed‑rate debt structure with no maturities until 2028. This combination of strong trading signals and resilient, government‑backed rental income has brought renewed focus to how Postal Realty’s growth and risk profile fit within...

If you are wondering whether Uniti Group’s share price reflects its true worth, you are not alone. This article focuses on what the current price might be telling you about value. The stock recently closed at US$7.50, with returns of 2.7% over 7 days, 1.8% over 30 days, 9.8% year to date, a 22.7% decline over 1 year and a 51.0% decline over 5 years. Recent news coverage around Uniti Group has highlighted its position as a telecommunications infrastructure owner, with commentary often...